7.10 vs. 6.05 mg/dl, p = 0.001) and a significantly higher level of biomarkers associated with inflammation (CRP and hs-CRP) and myocyte stress and injury (NT-proBNP and hs-cTnT) than non-AF individuals (Table 6). This evidence concerns the gene NPPB and atrial fibrillation.